Φορτώνει......
Type I interferon antagonists in clinical development for lupus
INTRODUCTION: Systemic lupus erythematosus (SLE) is a severe chronic and incurable autoimmune disease. Treatment includes glucocorticoids and small molecule immunosuppressants which typically result in partial responses, and hence there is a great need for new therapies. The type I interferon (IFN)...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Expert Opin Investig Drugs |
|---|---|
| Κύριοι συγγραφείς: | , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7924012/ https://ncbi.nlm.nih.gov/pubmed/32700979 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/13543784.2020.1797677 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|